Impact of Bright Light Therapy on Prader-Willi Syndrome

Description

This is a placebo controlled clinical trial to assess the utility of light therapy as a sufficient treatment for excessive daytime sleepiness in patients with Prader-Willi Syndrome

Conditions

Prader-Willi Syndrome, Excessive Daytime Sleepiness, Hyperphagia, Body Weight, Mood, Behavior

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a placebo controlled clinical trial to assess the utility of light therapy as a sufficient treatment for excessive daytime sleepiness in patients with Prader-Willi Syndrome

A Randomized, Double-Blind, Controlled Trial of Bright Light Therapy on All-Cause Excessive Daytime Sleepiness in Prader-Willi Syndrome

Impact of Bright Light Therapy on Prader-Willi Syndrome

Condition
Prader-Willi Syndrome
Intervention / Treatment

-

Contacts and Locations

Brooklyn

Maimonides Medical Center, Brooklyn, New York, United States, 11219

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Diagnosis of PWS confirmed by genetic testing
  • * Score of 12 or above on the Epworth Sleepiness Scale (ESS).
  • * Subjects with an eye condition that could be negatively affected by bright light such as patients with a history of retinal damage or patients needing photosensitizing medications
  • * A history of previous treatment with LT
  • * Patients presenting with active psychosis or mania

Ages Eligible for Study

6 Years to 18 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Maimonides Medical Center,

Deepan Singh, MD, PRINCIPAL_INVESTIGATOR, Maimonides Medical Center

Study Record Dates

2025-06